CDKN2A and neoplasm: ARF (p19ARF for human, p14ARF for mice) is a tumor suppressor transcribed from an alternative reading frame (ARF) of the p16INK4a cyclin-dependent kinase inhibitor; ARF disrupts P53-HDM2 complex by its interaction with HDM2.